Persistent Headache in Brain Metastases

Definition and Clinical Presentation

A headache in brain metastases is considered persistent when it continues despite initial medical management with corticosteroids, typically lasting beyond 1 month despite appropriate treatment, according to the American College of Chest Physicians 1
Headaches are one of the most common presenting symptoms in patients with brain metastases, along with mild neurologic impairment and seizures, as reported by the National Comprehensive Cancer Network 2, 3
The headache is typically caused by perilesional vasogenic edema that commonly accompanies brain metastases, best visualized on T2-weighted or fluid-attenuated inversion recovery MR images, as noted by the National Comprehensive Cancer Network 2
Approximately 15-20% of patients with brain metastases present with seizures, which may accompany headache, according to the National Comprehensive Cancer Network 2

Dexamethasone is the most commonly used glucocorticoid for brain tumor edema due to its minimal mineralocorticoid activity, as recommended by the American College of Chest Physicians 1
The European Federation of Neurological Sciences recommends starting dosages of dexamethasone between 4-8 mg/day 2
Systemic glucocorticoids are known to improve neurologic function only for a short time, with a maximum duration of 1 month, as reported by the American College of Chest Physicians 1
When headache persists beyond this timeframe despite appropriate steroid management, it is considered persistent, according to the American College of Chest Physicians 1

For patients with persistent headache despite optimal medical management, consideration should be given to surgical decompression for significant midline brain shift, compression of the ventricular system, obstructive hydrocephalus, intratumoral hemorrhage, or massive brain edema, as recommended by the National Comprehensive Cancer Network 2
Stereotactic radiosurgery (SRS) or whole brain radiation therapy (WBRT) may be considered to address the underlying metastatic lesions, as noted by the American College of Chest Physicians and the National Comprehensive Cancer Network 1, 4

The natural history of untreated cerebral metastases is dismal, with median survival reported as less than 2 months, according to the National Comprehensive Cancer Network 2
Persistent headache may indicate progressive disease and should prompt reassessment of treatment strategy, as recommended by the American College of Chest Physicians 1

Patients with brain metastases and headache should have close clinical follow-up to assess response to treatment, as recommended by the National Comprehensive Cancer Network 2
Ideally, steroid dose should be tapered as quickly as the clinical situation allows because of toxicity associated with long-term (>3 weeks) use, as noted by the National Comprehensive Cancer Network 2
Persistent headache despite optimal medical management should prompt re-imaging to assess disease progression, according to the American College of Chest Physicians 1